These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31272527)

  • 21. Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database.
    Park K; Soukavong M; Kim J; Kwon KE; Jin XM; Lee J; Yang BR; Park BJ
    Yonsei Med J; 2017 May; 58(3):564-569. PubMed ID: 28332362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of signal detection of tumour necrosis factor-α inhibitors using the Korea Adverse Events Reporting System Database, 2005-2016.
    Ha D; Lee SE; Song I; Lim SJ; Shin JY
    Clin Rheumatol; 2020 Feb; 39(2):347-355. PubMed ID: 31673980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Ezetimibe/Statin Combination and High-Dose Statin Therapy on Thyroid Autoimmunity in Women with Hashimoto's Thyroiditis and Cardiovascular Disease: A Pilot Study.
    Krysiak R; Szkróbka W; Okopień B
    Exp Clin Endocrinol Diabetes; 2016 Oct; 124(9):577-581. PubMed ID: 27657996
    [No Abstract]   [Full Text] [Related]  

  • 24. Ezetimibe plus moderate-intensity statin versus high-intensity statin.
    Drug Ther Bull; 2023 Mar; 61(3):38. PubMed ID: 36813278
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
    Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K
    Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
    Miyoshi T; Nakamura K; Doi M; Ito H
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):213-9. PubMed ID: 25896669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.
    Bissonnette S; Habib R; Sampalis F; Boukas S; Sampalis JS;
    Can J Cardiol; 2006 Oct; 22(12):1035-44. PubMed ID: 17036098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database.
    Choi JY; Choi JH; Kim MG; Rhie SJ
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34063258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal Detection for Cardiovascular Adverse Events of DPP-4 Inhibitors Using the Korea Adverse Event Reporting System Database, 2008-2016.
    Yi H; Lee JH; Shin JY
    Yonsei Med J; 2019 Feb; 60(2):200-207. PubMed ID: 30666842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.
    Ma YB; Chan P; Zhang Y; Tomlinson B; Liu Z
    Expert Opin Pharmacother; 2019 Jun; 20(8):917-928. PubMed ID: 30908086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMPROVE-IT: what have we learned?
    Banach M; Nikolic D; Rizzo M; Toth PP
    Curr Opin Cardiol; 2016 Jul; 31(4):426-33. PubMed ID: 27218683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.
    Ara R; Pandor A; Tumur I; Paisley S; Duenas A; Williams R; Wilkinson A; Durrington P; Chilcott J
    Clin Ther; 2008 Aug; 30(8):1508-23. PubMed ID: 18803993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy.
    De Ferrari GM; Perna GP; Nicosia A; Guasti L; Casu G; Cuccia C; Picco F; Strazzella C; Totaro R; Cercone S; Canullo L; Horack M; Lautsch D; Gitt AK; Di Biase M
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):485-490. PubMed ID: 29917002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin safety: an appraisal from the adverse event reporting system.
    Davidson MH; Clark JA; Glass LM; Kanumalla A
    Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ezetimibe on glycemic control: a systematic review and meta-analysis of randomized controlled trials.
    Wu H; Shang H; Wu J
    Endocrine; 2018 May; 60(2):229-239. PubMed ID: 29397561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial.
    Moriarty PM; Thompson PD; Cannon CP; Guyton JR; Bergeron J; Zieve FJ; Bruckert E; Jacobson TA; Kopecky SL; Baccara-Dinet MT; Du Y; Pordy R; Gipe DA;
    J Clin Lipidol; 2015; 9(6):758-769. PubMed ID: 26687696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin therapy with or without ezetimibe and the progression to diabetes.
    Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC
    J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statin-ezetimibe combination in hyperlipidemia treatment].
    Vareka T; Vítková D; Zeman M; Vecka M; Zák A
    Cas Lek Cesk; 2012; 151(1):17-21. PubMed ID: 22442891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
    Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J
    Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.